Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [911]
News [3681]
Articles [22]
Editorials [1]
Conferences [135]
elearning [0]
ESMO 35: Investigational drug afatinib benefits patients with NSCLC
ESMO 35: Investigational drug afatinib benefits patients with NSCLC
Gene could predict breast cancer patients' response to tamoxifen
Gene could predict breast cancer patients' response to tamoxifen
ESMO 35: New hope in metastatic hormone resistant prostate cancer
ESMO 35: New hope in metastatic hormone resistant prostate cancer
ESMO/JSMO Joint Symposium: Biomarkers and selected therapeutics in lung and GI cancer
ESMO/JSMO Joint Symposium: Biomarkers and selected therapeutics in lung and GI cancer
ESMO Session: Ovarian cancer: new biology, new targets
ESMO Session: Ovarian cancer: new biology, new targets
ESMO 2010: First-line FOLFIRI improves time to treatment failure versus standard therapy for advanced gastric cancer
ESMO 2010: First-line FOLFIRI improves time to treatment failure versus standard therapy for advanced gastric...
ESMO 35: Final results from landmark trial confirm survival benefits of EGFR mutations in lung cancer
ESMO 35: Final results from landmark trial confirm survival benefits of EGFR mutations in lung cancer
What's new for ipilimumab? Report from ESMO 2010
What's new for ipilimumab? Report from ESMO 2010
ESMO Session: Targeted agents in prostate cancer – Changing the paradigms
ESMO Session: Targeted agents in prostate cancer – Changing the paradigms
ESMO Session: Breast cancer challenges in the setting of curable disease
ESMO Session: Breast cancer challenges in the setting of curable disease

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation